Viridian Therapeutics, Inc. VRDN Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s other noncash income (expense)?
- Viridian Therapeutics, Inc. (VRDN) reported other noncash income (expense) of -$169K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s other noncash income (expense) changed year-over-year?
- Viridian Therapeutics, Inc.'s other noncash income (expense) decreased by 2916.7% year-over-year, from $6K to -$169K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.